Therapeutic levels of sodium valproate inhibit mitotic indices in cells of neural origin

This publication has 12 references indexed in Scilit:

• A short‐term screening test for teratogens using differentiating neuroblastoma cells in vitro
  Teratology, 1984
• Plasma protein‐binding and CSF concentrations of valproic acid in man following acute oral dosing.
  British Journal of Clinical Pharmacology, 1983
• VALPROIC ACID AND SPINA BIFIDA
  The Lancet, 1982
• MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTS
  The Lancet, 1982
• Asymptomatic Hyperammonemia in Patients Receiving Valproic Acid
  Archives of Neurology, 1982
• A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations
  Life Sciences, 1981
• SECONDARY HYPERAMMONÆMIA: A POSSIBLE MECHANISM FOR VALPROATE ENCEPHALOPATHY
  The Lancet, 1980
• Detection of teratogenic compounds using differentiating embryonic cells in culture
  In Vitro Cellular & Developmental Biology - Plant, 1980
• Transmission of valproic acid (Depakene) across theplacenta: Half-life of the drug in mother and baby
  The Journal of Pediatrics, 1979
• Sodium Valproate
  Drugs, 1977